Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmketamine vs dexmedetomidine for drug-induced sleep endoscopy in children with obstructive sleep apnea
ChiCTR2100045914Phase 4Recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in obstructive sleep apnea hypopnea syndrome (OSAHS) comparing Dexmedetomidine group with Esketamine group (2 arms). Primary endpoints: Heart rate, Pulse oxygen saturation and 3 more. Started Jun 2021; status: recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR2100045914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045914.